EFFECTS OF ITRACONAZOLE ON THE PHARMACOKINETICS OF COPANLISIB, A NOVEL PAN-CLASS I PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR IN CANCER SUBJECTS. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sawyer, MB
  • Spreafico, A
  • Hirte, Holger
  • Renouf, DJ
  • Huang, F
  • Reschke, S
  • Zhang, J
  • Yan, Z
  • Genvresse, I
  • Cisternas, G
  • Kelly, A
  • Khan, F
  • Reif, S
  • Granvil, C

publication date

  • March 1, 2018